
8th Conference on Liver Disease in Africa (COLDA) 2025
18 – 20 September 2025
MD, PhD
MRC Unit The Gambia at LSHTM, The Gambia
Dr. Gibril Ndow is the head of the Hepatitis Research Group at the MRC Unit The Gambia at LSHTM and an honorary research fellow at Imperial College London.
Dr. Ndow coordinates the PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa, www.prolifica.africa) research program in The Gambia and Senegal and leads several ancillary hepatitis B studies at the MRC Gambia.
Dr. Ndow’s research investigates the mechanisms underlying disease progression and surface antigen loss in Africans with chronic hepatitis B infection, and aims to identify new biomarkers of disease severity and targets for curative treatment.
This module focuses on strategies and real-world experiences aimed at eliminating vertical transmission of hepatitis B, alongside HIV and syphilis, in African settings. Through case studies from The Gambia, Namibia, and broader contexts, participants will explore implementation successes, challenges, and the impact of funding constraints on triple elimination efforts.
What Will Set You Apart?
By completing this module, you will:
Is This Program for You?
This program is designed for healthcare providers, program managers, policymakers, and public health professionals engaged in maternal and child health, infectious disease control, and elimination programs in Africa. It is particularly valuable for those involved in planning and implementing integrated vertical transmission prevention strategies under resource-limited conditions.
What Will You Cover in This Module?